de AllianceBernstein Ligand Pharmaceuticals LGND Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 5.41 M | Comprar |
27,095
+2,800
| +12% | +USD 660 k | ﹤0.01% | 1501 |
|
|
2026
Q1 | USD 4.59 M | Comprar |
24,295
+124
| +0.5% | +USD 24.5 k | ﹤0.01% | 1577 |
|
|
2025
Q4 | USD 4.57 M | Comprar |
24,171
+1,918
| +9% | +USD 369 k | ﹤0.01% | 1580 |
|
|
2025
Q3 | USD 3.94 M | Comprar |
22,253
+1,576
| +8% | +USD 234 k | ﹤0.01% | 1634 |
|
|
2025
Q2 | USD 2.35 M | Mantener |
20,677
| – | – | ﹤0.01% | 1853 |
|
|
2025
Q1 | USD 2.17 M | Comprar |
20,677
+31
| +0.2% | +USD 3.51 k | ﹤0.01% | 1847 |
|
|
2024
Q4 | USD 2.21 M | Vender |
20,646
-1,460
| -7% | -USD 165 k | ﹤0.01% | 1908 |
|
|
2024
Q3 | USD 2.21 M | Mantener |
22,106
| – | – | ﹤0.01% | 1910 |
|
|
2024
Q2 | USD 1.86 M | Vender |
22,106
-913
| -4% | -USD 72.7 k | ﹤0.01% | 1999 |
|
|
2024
Q1 | USD 1.68 M | Comprar |
23,019
+1,460
| +7% | +USD 108 k | ﹤0.01% | 2009 |
|
|
2023
Q4 | USD 1.54 M | Vender |
21,559
-20
| -0.1% | -USD 1.18 k | ﹤0.01% | 2066 |
|
|
2023
Q3 | USD 1.29 M | Mantener |
21,579
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q2 | USD 1.56 M | Vender |
21,579
-2,311
| -10% | -USD 173 k | ﹤0.01% | 2039 |
|
|
2023
Q1 | USD 1.76 M | Vender |
23,890
-1,434
| -6% | -USD 102 k | ﹤0.01% | 1939 |
|
|
2022
Q4 | USD 1.69 M | Vender |
25,324
-15,245
| -38% | -USD 991 k | ﹤0.01% | 2018 |
|
|
2022
Q3 | USD 2.18 M | Vender |
40,569
-158
| -0.4% | -USD 9.29 k | ﹤0.01% | 1834 |
|
|
2022
Q2 | USD 2.27 M | Comprar |
40,727
+70
| +0.2% | +USD 3.97 k | ﹤0.01% | 1881 |
|
|
2022
Q1 | USD 2.85 M | Comprar |
40,657
+199
| +0.5% | +USD 14.4 k | ﹤0.01% | 1880 |
|
|
2021
Q4 | USD 3.9 M | Vender |
40,458
-3,679
| -8% | -USD 340 k | ﹤0.01% | 1755 |
|
|
2021
Q3 | USD 3.84 M | Vender |
44,137
-23,032
| -34% | -USD 1.78 M | ﹤0.01% | 1753 |
|
|
2021
Q2 | USD 5.5 M | Vender |
67,169
-4,745
| -7% | -USD 395 k | ﹤0.01% | 1558 |
|
|
2021
Q1 | USD 6.84 M | Comprar |
71,914
+1,310
| +2% | +USD 124 k | ﹤0.01% | 1389 |
|
|
2020
Q4 | USD 4.38 M | Vender |
70,604
-26,551
| -27% | -USD 1.51 M | ﹤0.01% | 1563 |
|
|
2020
Q3 | USD 5.78 M | Vender |
97,155
-10,616
| -10% | -USD 724 k | ﹤0.01% | 1273 |
|
|
2020
Q2 | USD 7.52 M | Vender |
107,771
-1,459
| -1% | -USD 92.5 k | ﹤0.01% | 1123 |
|
|
2020
Q1 | USD 4.96 M | Comprar |
109,230
+449
| +0.4% | +USD 25.4 k | ﹤0.01% | 1189 |
|
|
2019
Q4 | USD 7.08 M | Vender |
108,781
-2,773
| -2% | -USD 185 k | ﹤0.01% | 1234 |
|
|
2019
Q3 | USD 6.93 M | Vender |
111,554
-1,924
| -2% | -USD 121 k | ﹤0.01% | 1205 |
|
|
2019
Q2 | USD 8.08 M | Vender |
113,478
-4,889
| -4% | -USD 360 k | 0.01% | 1145 |
|
|
2019
Q1 | USD 9.28 M | Comprar |
118,367
+4,536
| +4% | +USD 344 k | 0.01% | 1090 |
|
|
2018
Q4 | USD 9.6 M | Comprar |
113,831
+39,437
| +53% | +USD 4.2 M | 0.01% | 1008 |
|
|
2018
Q3 | USD 12.7 M | Vender |
74,394
-481
| -0.6% | -USD 72.5 k | 0.01% | 911 |
|
|
2018
Q2 | USD 9.7 M | Comprar |
74,875
+1,555
| +2% | +USD 174 k | 0.01% | 980 |
|
|
2018
Q1 | USD 7.55 M | Vender |
73,320
-513
| -0.7% | -USD 50.7 k | 0.01% | 1027 |
|
|
2017
Q4 | USD 6.31 M | Mantener |
73,833
| – | – | ﹤0.01% | 1113 |
|
|
2017
Q3 | USD 6.27 M | Mantener |
73,833
| – | – | ﹤0.01% | 1112 |
|
|
2017
Q2 | USD 5.59 M | Comprar |
73,833
+12,279
| +20% | +USD 859 k | ﹤0.01% | 1157 |
|
|
2017
Q1 | USD 4.06 M | Comprar |
61,554
+9,602
| +18% | +USD 632 k | ﹤0.01% | 1318 |
|
|
2016
Q4 | USD 3.29 M | Mantener |
51,952
| – | – | ﹤0.01% | 1471 |
|
|
2016
Q3 | USD 3.31 M | Mantener |
51,952
| – | – | ﹤0.01% | 1394 |
|
|
2016
Q2 | USD 3.86 M | Comprar |
51,952
+7,374
| +17% | +USD 547 k | ﹤0.01% | 1197 |
|
|
2016
Q1 | USD 2.98 M | Vender |
44,578
-5,129
| -10% | -USD 312 k | ﹤0.01% | 1328 |
|
|
2015
Q4 | USD 3.36 M | Vender |
49,707
-6,012
| -11% | -USD 371 k | ﹤0.01% | 1249 |
|
|
2015
Q3 | USD 2.98 M | Vender |
55,719
-6,460
| -10% | -USD 392 k | ﹤0.01% | 1348 |
|
|
2015
Q2 | USD 3.91 M | Vender |
62,179
-1,603
| -3% | -USD 87.5 k | ﹤0.01% | 1250 |
|
|
2015
Q1 | USD 3.07 M | Mantener |
63,782
| – | – | ﹤0.01% | 1426 |
|
|
2014
Q4 | USD 2.12 M | Mantener |
63,782
| – | – | ﹤0.01% | 1718 |
|
|
2014
Q3 | USD 1.87 M | Mantener |
63,782
| – | – | ﹤0.01% | 1774 |
|
|
2014
Q2 | USD 2.48 M | Vender |
63,782
-168
| -0.3% | -USD 6.82 k | ﹤0.01% | 1614 |
|
|
2014
Q1 | USD 2.68 M | Comprar |
63,950
+9,607
| +18% | +USD 400 k | ﹤0.01% | 1493 |
|
|
2013
Q4 | USD 1.78 M | Vender |
54,343
-3,036
| -5% | -USD 98.9 k | ﹤0.01% | 1802 |
|
|
2013
Q3 | USD 1.55 M | Vender |
57,379
-3,719
| -6% | -USD 105 k | ﹤0.01% | 1866 |
|
|
2013
Q2 | USD 1.43 M | Comprar |
+61,098
| Nuevas | +USD 1.1 M | ﹤0.01% | 1854 |
|
Otros fondos que tienen LGND en su cartera
Posición de AllianceBernstein en LGND: resumen de T2 2026
AllianceBernstein aumentó su participación en Ligand Pharmaceuticals (LGND) en 12% durante T2 2026, al comprar aproximadamente USD 660 k y elevar la posición a 27,095 acciones con un valor de USD 5.41 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1501.
AllianceBernstein reportó por primera vez una posición en LGND en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 12.7 M en T3 2018. Al cierre de T2 2026, 418 fondos que sigue Wall St. Rank mantienen una posición en LGND.
- Al cierre de T2 2026, AllianceBernstein tenía 27,095 acciones de Ligand Pharmaceuticals con un valor de USD 5.41 M.
- AllianceBernstein compró 2,800 acciones de Ligand Pharmaceuticals en T2 2026, por un monto estimado de USD 660 k.
- Ligand Pharmaceuticals representó ﹤0.01% de la cartera de AllianceBernstein en T2 2026 y fue su posición número 1501.
- AllianceBernstein reportó por primera vez una posición en Ligand Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de AllianceBernstein en Ligand Pharmaceuticals alcanzó su máximo de USD 12.7 M en T3 2018.
- Al cierre de T2 2026, 418 fondos que sigue Wall St. Rank tenían Ligand Pharmaceuticals en cartera.
Según el Informe 13F de AllianceBernstein correspondiente a T2 2026, presentado el 14 ago 2026.